Kymera Therapeutics (KYMR) Q4 2024 Earnings

Oct 31Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.83
-0.64
-0.44
-0.25

Details

Expected EPS
-0.832283
Actual EPS
-0.82
Surprise EPS
0.01
Surprise Percent
+1.48%

Description

⁨Kymera Therapeutics⁩ (⁦KYMR⁩) has reported earnings of ⁦-0.82⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts